| Bioactivity | Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydrochloride, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms[1][2]. |
| Invitro | Cefozopran (SCE-2787) is a fourth-generation cephalosporin that has good activity against gram-positive organisms including methicillin-susceptible staphylococci, enterococci, and viridans group streptococci; and against gram-negative organisms including hemophilus influenza. Moreover, cefozopran has comparatively good activity against enterococci and P. aeruginosa, which are refractory to other cephalosporins[2]. |
| Name | Cefozopran hydrochloride |
| CAS | 113981-44-5 |
| Formula | C19H18ClN9O5S2 |
| Molar Mass | 551.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Cefozopran hydrochloride
CAS: 113981-44-5 F: C19H18ClN9O5S2 W: 551.99
Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydroch
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.